In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $105.27 in the prior trading day, Novo Nordisk ADR (NYSE: NVO) closed at $102.63, down -2.51%. In other words, the price has decreased by -$2.51 from its previous closing price. On the day, 5.85 million shares were traded. NVO stock price reached its highest trading level at $103.22 during the session, while it also had its lowest trading level at $101.5113.
Ratios:
Our goal is to gain a better understanding of NVO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.56 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.23. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on May 30, 2024, initiated with a Buy rating and assigned the stock a target price of $156.
On April 12, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $163.
On January 23, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $120.Morgan Stanley initiated its Overweight rating on January 23, 2024, with a $120 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVO now has a Market Capitalization of 446045356032 and an Enterprise Value of 450784624640. As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.28, and their Forward P/E ratio for the next fiscal year is 25.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.71 while its Price-to-Book (P/B) ratio in mrq is 18.99. Its current Enterprise Value per Revenue stands at 1.666 whereas that against EBITDA is 3.538.
Stock Price History:
Over the past 52 weeks, NVO has reached a high of $148.15, while it has fallen to a 52-week low of $94.73. The 50-Day Moving Average of the stock is -11.61%, while the 200-Day Moving Average is calculated to be -19.76%.
Shares Statistics:
The stock has traded on average 4.57M shares per day over the past 3-months and 6145300 shares per day over the last 10 days, according to various share statistics. A total of 3.38B shares are outstanding, with a floating share count of 3.34B. Insiders hold about 0.02% of the company’s shares, while institutions hold 10.03% stake in the company. Shares short for NVO as of 1730332800 were 6052242 with a Short Ratio of 1.32, compared to 1727654400 on 7030230. Therefore, it implies a Short% of Shares Outstanding of 6052242 and a Short% of Float of 0.19.
Dividends & Splits
In the trailing 12 months, NVO’s forward annual dividend rate was 9.9, compared to 1.45 this year. Against a Trailing Annual Dividend Yield of 0.09404389The stock’s 5-year Average Dividend Yield is 1.47.
